Show simple item record

dc.contributor.authorEvans, C
dc.contributor.authorJones, CE
dc.contributor.authorPrendergast, AJ
dc.date.accessioned2019-04-24T11:12:29Z
dc.date.available2016-01-21
dc.date.available2019-04-24T11:12:29Z
dc.date.issued2016-03-31
dc.identifier.citationEvans C, Jones CE, Prendergast AJ. HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination. Lancet Infect Dis. 2016;16:e92–e107.en_US
dc.identifier.issn1473-3099
dc.identifier.urihttp://openaccess.sgul.ac.uk/107658/
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/57000
dc.description.abstractThe number of infants infected with HIV is declining with the rise in interventions for the elimination of paediatric HIV infection, but the number of uninfected infants exposed to HIV through their HIV-infected mothers is increasing. Interest in the health outcomes of HIV-exposed, uninfected infants has grown in the past decade, with several studies suggesting that these infants have increased mortality rates, increased infectious morbidity, and impaired growth compared with HIV-unexposed infants. However, heterogeneous results might reflect the inherent challenges in studies of HIV-exposed, uninfected infants, which need large populations with appropriate, contemporaneous comparison groups and repeated HIV testing throughout the period of breastfeeding. We review the effects of HIV exposure on mortality, morbidity, and growth, discuss the immunological abnormalities identified so far, and provide an overview of interventions that could be effective in this susceptible population. As the number of infants infected with HIV declines, the health needs of HIV-exposed, uninfected infants should be prioritised further, to ensure that post-2015 Sustainable Development Goals are achieved.en_US
dc.description.sponsorshipCE is funded by the National Institute for Health Research. AJP is funded by the Wellcome Trust (108065/Z/15/Z).en_US
dc.format.extente92 - e107
dc.languageeng
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofLancet Infect Dis
dc.rightsCC-NC ND
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectAfricaen_US
dc.subjectAntiviral Agentsen_US
dc.subjectFemaleen_US
dc.subjectHIV Infectionsen_US
dc.subjectHumansen_US
dc.subjectImmune Systemen_US
dc.subjectInfanten_US
dc.subjectInfant, Newbornen_US
dc.subjectInfectious Disease Transmission, Verticalen_US
dc.subjectPregnancyen_US
dc.subjectPregnancy Complications, Infectiousen_US
dc.subjectRisk Factorsen_US
dc.titleHIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination.en_US
dc.typeArticleen_US
dc.rights.holder2016 Elsevier Ltd.
dc.identifier.doi10.1016/S1473-3099(16)00055-4
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/27049574en_US
pubs.issue6en_US
pubs.notesNo embargoen_US
pubs.publication-statusPublisheden_US
pubs.volume16en_US
dcterms.dateAccepted2016-01-21
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

CC-NC ND
Except where otherwise noted, this item's license is described as CC-NC ND